New chromosome abnormalities and lack of BCL-6 gene rearrangements in Argentinean diffuse large B-cell lymphomas

European Journal of Haematology
Roxana CerretiniIrma Slavutsky

Abstract

Diffuse large B-cell lymphoma (DLBCL) is the most common form of non-Hodgkin lymphomas. Cytogenetic studies have revealed a broad spectrum of clonal genetic abnormalities and complex karyotypes. The purpose of this study was to contribute to the understanding of the genomic alterations associated with this group of lymphomas. Cytogenetic, fluorescence in situ hybridization (FISH) and molecular analyses were performed in 30 cases with DLBCL: 20 de novo DLBCL (dn-DLBCL) and 10 DLBCL secondary to follicular lymphoma (S-DLBCL). A total of 37 different structural chromosomal rearrangements were found: 27% translocations, 54% deletions, and 19% other alterations. Chromosomes 8, 6, 2, and 9 were the most commonly affected. Interestingly, translocation t(3;14)(q27;q32) and/or BCL-6 gene rearrangements were not observed either by cytogenetic studies or by FISH analysis. Fifteen novel cytogenetic alterations were detected, among them translocations t(2;21)(p11;q22) and t(8;18)(q24;p11.3) appeared as sole structural abnormalities. Translocation t(14;18)(q32;q21) and/or BCL-2-IGH gene rearrangements were the genomic alterations most frequently observed: 50% of S-DLBCL and 30% of dn-DLBCL. Deletions del(4)(q21), del(6)(q27), del(8)(q11), an...Continue Reading

References

Nov 1, 1990·American Journal of Hematology·H FujiiF Matuyama
Jan 1, 1986·Leukemia Research·V Brito-BabapulleD Catovsky
Apr 1, 1986·Cancer Genetics and Cytogenetics·R Becher
Dec 1, 1985·Cancer Genetics and Cytogenetics·K OhyashikiA A Sandberg
May 1, 1983·Cancer Genetics and Cytogenetics·I NordensonG Roos
Jan 1, 1995·Cytogenetics and Cell Genetics·M HöglundF Mitelman
Jan 1, 1995·Cytogenetics and Cell Genetics·M HöglundN Mandahl
Mar 1, 1994·Pediatric Hematology and Oncology·S P Attard-MontaltoO B Eden
Nov 1, 1993·Brain and Cognition·P MontgomeryM Andberg
Sep 1, 1997·Cancer Genetics and Cytogenetics·M HumphreysN Nevin
Mar 25, 1999·European Journal of Haematology·M JerkemanF Mitelman
May 25, 1999·Genes, Chromosomes & Cancer·J C CigudosaR S Chaganti
Nov 9, 2000·Seminars in Hematology·R S ChagantiJ Teruya-Feldstein
Mar 10, 2001·Genes, Chromosomes & Cancer·D E HorsmanR D Gascoyne
Feb 19, 2002·Cancer Genetics and Cytogenetics·Bhavana J DaveWarren G Sanger
Apr 11, 2002·American Journal of Clinical Oncology·Akihiro TsukadairaKeishi Kubo
May 30, 2002·Cancer Genetics and Cytogenetics·Roxana CerretiniIrma Slavutsky
Jun 22, 2002·Proceedings of the National Academy of Sciences of the United States of America·Izidore S LossosRonald Levy
Aug 16, 2002·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Mattias BerglundSvetlana Lagercrantz
Jan 31, 2003·Genes, Chromosomes & Cancer·Siegfried JanzCharles S Rabkin
Sep 1, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Sílvia BeàElias Campo

❮ Previous
Next ❯

Related Concepts

Related Feeds

B-Cell Lymphoma

B-cell lymphomas include lymphomas that affect B cells. This subtype of cancer accounts for over 80% of non-Hodgkin lymphomas in the US. Here is the latest research.

Birth Defects

Birth defects encompass structural and functional alterations that occur during embryonic or fetal development and are present since birth. The cause may be genetic, environmental or unknown and can result in physical and/or mental impairment. Here is the latest research on birth defects.

BCL-2 Family Proteins

BLC-2 family proteins are a group that share the same homologous BH domain. They play many different roles including pro-survival signals, mitochondria-mediated apoptosis and removal or damaged cells. They are often regulated by phosphorylation, affecting their catalytic activity. Here is the latest research on BCL-2 family proteins.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.